Natco Pharma Acquires 49% Additional Stake in PT NATCO Lotus Farma, Wholly-Owns Subsidiary Now

Natco Pharma Ltd has acquired 49% of shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia, through its wholly-owned subsidiary NATCO Pharma Asia Pte. Ltd. This acquisition, costing IDR 14,075,400,000 (~X7.7 crores), makes Natco Pharma the sole owner of PT NATCO Lotus Farma. PT NATCO Lotus Farma, a pharmaceutical company based in Indonesia, had a turnover of IDR 5,073 million (~X 2.7 crores) in YTD Sep 2025, IDR 3,324 million (~X 1.6 crores) in April - March 2025, and nil in the previous years. This acquisition aligns with Natco Pharma's strategic expansion plans in the pharmaceutical industry.